Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Arron

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Biomarkers in Medicine|January 15, 2016
Biomarkers in the clinical development of asthma therapiesTracy L Staton, David F Choy, Joseph R Arron
Annual Review of Immunology|April 29, 2020
30 Years of Biotherapeutics Development-What Have We Learned?Nico Ghilardi, Rajita Pappu, Joseph R Arron, et al.
Annals of the American Thoracic Society|December 10, 2013
Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthmaJoseph R Arron, David F Choy, Heleen Scheerens, et al.
The Journal of Experimental Medicine|October 9, 2002
Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signalingJoseph R Arron, Yael Pewzner-Jung, Matthew C Walsh, et al.
Frontiers in Immunology|September 24, 2025
Breaking the cycle: should we target inflammation, fibrosis, or both?Sarah K Baxter, Ricardo A Irizarry-Caro, Jason A Vander Heiden, et al.
Nature|February 13, 2007
Chemical rescue of cleft palate and midline defects in conditional GSK-3beta miceKaren J Liu, Joseph R Arron, Kryn Stankunas, et al.
Annals of Translational Medicine|March 10, 2017
Accurately measuring and modeling Th2 and Th17 endotypes in severe asthmaKevin M Hart, David F Choy, Peter Bradding, et al.
Frontiers in Medicine|October 17, 2017
Interleukin-13 in Asthma and Other Eosinophilic DisordersEmma Doran, Fang Cai, Cécile T J Holweg, et al.
Clinical Immunology (Orlando, Fla.)|May 3, 2015
Stratified medicine in inflammatory disorders: From theory to practiceJoseph R Arron, Michael J Townsend, Mary E Keir, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2017
Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumabTracy L Staton, Joseph R Arron, Julie Olsson, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Biomarkers in Medicine|January 15, 2016
Biomarkers in the clinical development of asthma therapiesTracy L Staton, David F Choy, Joseph R Arron
Annual Review of Immunology|April 29, 2020
30 Years of Biotherapeutics Development-What Have We Learned?Nico Ghilardi, Rajita Pappu, Joseph R Arron, et al.
Annals of the American Thoracic Society|December 10, 2013
Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthmaJoseph R Arron, David F Choy, Heleen Scheerens, et al.
The Journal of Experimental Medicine|October 9, 2002
Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signalingJoseph R Arron, Yael Pewzner-Jung, Matthew C Walsh, et al.
Frontiers in Immunology|September 24, 2025
Breaking the cycle: should we target inflammation, fibrosis, or both?Sarah K Baxter, Ricardo A Irizarry-Caro, Jason A Vander Heiden, et al.
Nature|February 13, 2007
Chemical rescue of cleft palate and midline defects in conditional GSK-3beta miceKaren J Liu, Joseph R Arron, Kryn Stankunas, et al.
Annals of Translational Medicine|March 10, 2017
Accurately measuring and modeling Th2 and Th17 endotypes in severe asthmaKevin M Hart, David F Choy, Peter Bradding, et al.
Frontiers in Medicine|October 17, 2017
Interleukin-13 in Asthma and Other Eosinophilic DisordersEmma Doran, Fang Cai, Cécile T J Holweg, et al.
Clinical Immunology (Orlando, Fla.)|May 3, 2015
Stratified medicine in inflammatory disorders: From theory to practiceJoseph R Arron, Michael J Townsend, Mary E Keir, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2017
Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumabTracy L Staton, Joseph R Arron, Julie Olsson, et al.
Pageof 10